- Home
- AUPH vs NMM Comparison
AUPH vs NMM Comparison
Compare AUPH & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- NMM
- Stock Information
- Founded
- AUPH 1993
- NMM 2007
- Country
- AUPH Canada
- NMM Monaco
- Employees
- AUPH N/A
- NMM N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- NMM Marine Transportation
- Sector
- AUPH Health Care
- NMM Consumer Discretionary
- Exchange
- AUPH Nasdaq
- NMM Nasdaq
- Market Cap
- AUPH 1.1B
- NMM 1.3B
- IPO Year
- AUPH 1999
- NMM 2007
- Fundamental
- Price
- AUPH $7.93
- NMM $43.65
- Analyst Decision
- AUPH Strong Buy
- NMM Strong Buy
- Analyst Count
- AUPH 3
- NMM 1
- Target Price
- AUPH $10.33
- NMM $80.00
- AVG Volume (30 Days)
- AUPH 1.0M
- NMM 105.3K
- Earning Date
- AUPH 02-27-2025
- NMM 02-13-2025
- Dividend Yield
- AUPH N/A
- NMM 0.46%
- EPS Growth
- AUPH N/A
- NMM N/A
- EPS
- AUPH N/A
- NMM 12.15
- Revenue
- AUPH $220,361,000.00
- NMM $1,334,066,000.00
- Revenue This Year
- AUPH $36.97
- NMM N/A
- Revenue Next Year
- AUPH $16.43
- NMM $6.96
- P/E Ratio
- AUPH N/A
- NMM $3.59
- Revenue Growth
- AUPH 38.72
- NMM 2.08
- 52 Week Low
- AUPH $4.71
- NMM $32.75
- 52 Week High
- AUPH $10.67
- NMM $65.89
- Technical
- Relative Strength Index (RSI)
- AUPH 47.47
- NMM 48.47
- Support Level
- AUPH $7.50
- NMM $42.22
- Resistance Level
- AUPH $8.12
- NMM $45.65
- Average True Range (ATR)
- AUPH 0.27
- NMM 1.50
- MACD
- AUPH 0.02
- NMM 0.24
- Stochastic Oscillator
- AUPH 53.49
- NMM 58.16
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through chartering of vessels, voyage contracts. Geographically, it generates majority revenue from Asia.